https://pharmadog.xyz/news/421335 pharmadog en 2026-09-18T14:46:20.000Z Anthropic opens limited access to Mythos AI for life-science researchers https://pharmadog.xyz/news/421399 pharmadog en 2026-09-18T14:43:50.000Z GSK adds two China cancer-therapy licensing deals, keeping pace with industry partnership surge https://pharmadog.xyz/news/421400 pharmadog en 2026-09-18T14:24:00.000Z Ultragenyx prices Sanfilippo gene therapy at $4 million as it gains a second FDA approval; Bristol Myers halts Orum cancer drug https://pharmadog.xyz/news/421083 pharmadog en 2026-09-18T13:59:04.000Z Xenon shares plunge 23% after voluntary hold on psychiatry trials, despite filing NDA for epilepsy drug https://pharmadog.xyz/news/421103 pharmadog en 2026-09-18T13:42:29.000Z Roche opens new research center in Boston, expanding its local presence https://pharmadog.xyz/news/421104 pharmadog en 2026-09-18T13:38:24.000Z IN8bio appoints Oxana Polyakova as senior vice president of R&D https://pharmadog.xyz/news/421105 pharmadog en 2026-09-18T13:29:38.000Z U.S. drafts new investment rules to keep pharma licensing deals with China viable https://pharmadog.xyz/news/420915 pharmadog en 2026-09-18T12:32:03.000Z Ultragenyx receives FDA approval for Fayuvi, first therapy for Sanfilippo syndrome type A, priced at $3.95 M https://pharmadog.xyz/news/420916 pharmadog en 2026-09-18T12:19:39.000Z BMS drops Orum’s targeted degrader after Phase 1 results https://pharmadog.xyz/news/420935 pharmadog en 2026-09-18T12:11:48.000Z Panel discusses how questions about health equity shape public trust in science https://pharmadog.xyz/news/420723 pharmadog en 2026-09-18T11:00:21.000Z Legend Biotech appoints former Novartis exec Ingrid Zhang as CEO amid falling share price https://pharmadog.xyz/news/421202 pharmadog en 2026-09-18T09:47:00.000Z Biopharma prediction markets raise insider-info concerns, regulators weigh oversight https://pharmadog.xyz/news/420155 pharmadog en 2026-09-18T08:30:00.000Z Doctors urged to tell patients Asian glow signals health risk, not harmless quirk https://pharmadog.xyz/news/420156 pharmadog en 2026-09-18T08:30:00.000Z Rise in Young Men Seeking Cosmetic Surgery Driven by Social Media Influence, Surgeon Observes https://pharmadog.xyz/news/420157 pharmadog en 2026-09-18T08:30:00.000Z Sudan civil war forces cancer patients to endure hazardous journeys for treatment https://pharmadog.xyz/news/420158 pharmadog en 2026-09-18T08:30:00.000Z Geriatrician urges careful use of AI predictions for older patients https://pharmadog.xyz/news/420530 pharmadog en 2026-09-18T05:33:00.000Z Xenon pauses enrollment in phase 3 depression trials after reports of psychosis and other neuropsychiatric events https://pharmadog.xyz/news/420086 pharmadog en 2026-09-18T03:42:00.000Z BMS abandons $100 million Orum degrader-antibody conjugate after early phase-1 results https://pharmadog.xyz/news/419918 pharmadog en 2026-09-18T03:01:00.000Z Electra Therapeutics raises $350 million in oversubscribed IPO https://pharmadog.xyz/news/418679 pharmadog en 2026-09-18T00:43:12.000Z Electra Therapeutics raises $350 million in Nasdaq IPO to fund commercial expansion https://pharmadog.xyz/news/418743 pharmadog en 2026-09-18T00:42:00.000Z Electra Therapeutics raises $350M in biotech IPO, fueling rare disease drug development https://pharmadog.xyz/news/418171 pharmadog en 2026-09-17T22:09:30.000Z Health secretary Kennedy launches program to accelerate autism diagnosis https://pharmadog.xyz/news/421402 pharmadog en 2026-09-17T21:39:00.000Z Lisata acquires Marea Therapeutics, securing $225M financing to advance two mid-stage drugs https://pharmadog.xyz/news/417835 pharmadog en 2026-09-17T20:40:04.000Z Health Secretary RFK Jr. delivers anti‑vaccine keynote at Children’s Health Defense conference https://pharmadog.xyz/news/417623 pharmadog en 2026-09-17T19:19:36.000Z Bristol Myers ends $100M Phase 1 cancer ADC program https://pharmadog.xyz/news/417347 pharmadog en 2026-09-17T18:56:20.000Z CMS offers Medicare pricing program exemptions to drugmakers who add Medicaid rebates https://pharmadog.xyz/news/417348 pharmadog en 2026-09-17T18:27:10.000Z FDA confronts surge of Chinese biotech firms as they become key industry players https://pharmadog.xyz/news/417706 pharmadog en 2026-09-17T18:26:43.000Z FDA Approves First Gene Therapy for Pediatric Patients with Sanfilippo Syndrome Type A https://pharmadog.xyz/news/417223 pharmadog en 2026-09-17T18:00:00.000Z Rare genetic variant linked to much higher lung cancer risk in never-smokers https://pharmadog.xyz/news/417179 pharmadog en 2026-09-17T17:01:24.000Z UK parliamentary committees demand probe into cost of US-UK pharma trade deal https://pharmadog.xyz/news/417011 pharmadog en 2026-09-17T16:47:15.000Z Cellares signs first Asian manufacturing deal with Taiwan's GenomeFrontier Therapeutics for CAR-T production https://pharmadog.xyz/news/417055 pharmadog en 2026-09-17T16:26:18.000Z Definium shares new psychedelics data and court reprieve for international researchers discussed on The Readout LOUD https://pharmadog.xyz/news/417075 pharmadog en 2026-09-17T15:55:00.000Z Novo and Orbis strike up to $1.4 billion partnership to develop oral peptide macrocycles for cardiometabolic disease https://pharmadog.xyz/news/416844 pharmadog en 2026-09-17T15:28:07.000Z Michael J. Fox Foundation backs Ariadne Bio's non-hallucinogenic psychedelic for Parkinson's https://pharmadog.xyz/news/416867 pharmadog en 2026-09-17T15:21:34.000Z Novo Nordisk signs up to $1.4 billion deal with Orbis Medicines to develop oral macrocycle cardiometabolic drugs https://pharmadog.xyz/news/420866 pharmadog en 2026-09-17T15:18:00.000Z Chutes & Ladders—Legend poaches Novartis vet to boost commercial potential https://pharmadog.xyz/news/416845 pharmadog en 2026-09-17T15:17:40.000Z CMS launches 10-year ACCESS health-tech pilot for Medicare https://pharmadog.xyz/news/416907 pharmadog en 2026-09-17T15:09:00.000Z North Immunology to go public via reverse merger with Aethlon, targeting eczema market https://pharmadog.xyz/news/416611 pharmadog en 2026-09-17T14:57:41.000Z Kennedy appoints eight specialists to U.S. Preventive Services Task Force, ending year-long vacancy https://pharmadog.xyz/news/416567 pharmadog en 2026-09-17T14:52:34.000Z Endpoints 11 reveals 2026’s most promising biotech startups at Boston gala https://pharmadog.xyz/news/416568 pharmadog en 2026-09-17T14:34:00.000Z Roche's Lunsumio clears Phase 3 hurdle, paving way for broader label in indolent lymphoma https://pharmadog.xyz/news/416612 pharmadog en 2026-09-17T14:30:37.000Z Startup launches trial of psychedelic-style drug for Parkinson’s symptom https://pharmadog.xyz/news/416613 pharmadog en 2026-09-17T14:17:03.000Z FDA staffing shortage limits ability to hire new employees, raising concerns for health-care oversight https://pharmadog.xyz/news/416614 pharmadog en 2026-09-17T14:11:18.000Z Study finds purer fentanyl will not curb U.S. overdose deaths https://pharmadog.xyz/news/416591 pharmadog en 2026-09-17T14:01:44.000Z Webinar Explores Manufacturing Risks and Partner Strategies for the Next Five Years https://pharmadog.xyz/news/416443 pharmadog en 2026-09-17T13:42:03.000Z Biotech sector expected to weather Fed rate hike despite higher capital costs https://pharmadog.xyz/news/416444 pharmadog en 2026-09-17T13:39:53.000Z Novartis' $12B Avidity deal falters as DM1 therapy misses Phase 3 endpoint https://pharmadog.xyz/news/416419 pharmadog en 2026-09-17T13:11:09.000Z General Catalyst outlines tech collaborations with Summa Health after hospital acquisition https://pharmadog.xyz/news/416615 pharmadog en 2026-09-17T13:09:13.000Z Zocdoc adds chatbot scheduling and updates on Medicare ACCESS https://pharmadog.xyz/news/416276 pharmadog en 2026-09-17T12:19:58.000Z Longeveron shares plunge 57% after stem-cell therapy fails in mid-stage heart trial https://pharmadog.xyz/news/417598 pharmadog en 2026-09-17T12:17:00.000Z Goa Therapeutics launches with $15.5M funding to develop fast-acting alcohol sobering drug https://pharmadog.xyz/news/416277 pharmadog en 2026-09-17T12:13:55.000Z Roche commits up to $1 billion to develop bispecific antibodies with Dualitas https://pharmadog.xyz/news/416127 pharmadog en 2026-09-17T11:59:57.000Z FDA hiring delays persist despite expectations, and Bavarian Nordic names new CEO https://pharmadog.xyz/news/417936 pharmadog en 2026-09-17T11:55:00.000Z Clinical trial enrollment crisis threatens billions in revenue and patient access https://pharmadog.xyz/news/416083 pharmadog en 2026-09-17T11:15:40.000Z Bavarian Nordic appoints former Sanofi, AstraZeneca and Pfizer executive Tarja Stenvall as CEO https://pharmadog.xyz/news/416084 pharmadog en 2026-09-17T11:00:05.000Z Orbis Medicines signs up to $1.4 billion partnership with Novo to develop macrocycle drugs for cardiometabolic disease https://pharmadog.xyz/news/415959 pharmadog en 2026-09-17T10:30:00.000Z Biotech hedge fund launches North Immunology to develop long-acting antibody for atopic dermatitis https://pharmadog.xyz/news/415960 pharmadog en 2026-09-17T10:30:00.000Z Sellas’ Phase 3 REGAL AML Immunotherapy Study Delayed, Forecast to Miss Survival Endpoint https://pharmadog.xyz/news/415939 pharmadog en 2026-09-17T10:13:23.000Z Experts discuss wet AMD treatment limits and need for longer lasting therapies https://pharmadog.xyz/news/416542 pharmadog en 2026-09-17T10:02:00.000Z Lisata Therapeutics merges with Marea Therapeutics in reverse merger after failed Kuva deal https://pharmadog.xyz/news/415703 pharmadog en 2026-09-17T10:00:00.000Z Roche partners with Dualitas Therapeutics in up to $1 billion deal to screen bispecific antibodies for immune diseases https://pharmadog.xyz/news/417154 pharmadog en 2026-09-17T09:44:00.000Z Rare inherited EGFR mutation raises lung cancer risk 62-fold in never-smokers, 25-fold in smokers https://pharmadog.xyz/news/415516 pharmadog en 2026-09-17T08:30:00.000Z Shift away from oppositional defiant disorder reflects changing views on child noncompliance https://pharmadog.xyz/news/415515 pharmadog en 2026-09-17T08:30:00.000Z FDA hiring drive to add 2,000 staff stalls due to overwhelmed HR center https://pharmadog.xyz/news/416228 pharmadog en 2026-09-17T08:07:00.000Z Roche inks $1 billion deal with Dualitas to screen 300,000 bispecific combos for immunology and inflammation https://pharmadog.xyz/news/416398 pharmadog en 2026-09-17T07:43:00.000Z North Immunology to go public via reverse merger, targeting eczema with bispecific antibody https://pharmadog.xyz/news/415347 pharmadog en 2026-09-17T07:42:48.000Z England's NHS to fund AstraZeneca's Enhertu for metastatic breast cancer after U.K.-U.S. pricing pact https://pharmadog.xyz/news/415328 pharmadog en 2026-09-17T07:00:00.000Z Over 15,000 Science/R&D jobs and 10,800 Clinical roles posted on BioSpace in first eight months of 2026 https://pharmadog.xyz/news/415327 pharmadog en 2026-09-17T07:00:00.000Z Biopharma hiring surges in Massachusetts and California, with science/R&D and clinical roles leading demand https://pharmadog.xyz/news/416059 pharmadog en 2026-09-17T06:27:00.000Z SK Biopharma signs $315 million deal with 1ST Biotherapeutics for preclinical Parkinson’s drug 1ST-104 https://pharmadog.xyz/news/415890 pharmadog en 2026-09-17T04:12:00.000Z Longeveron’s pediatric heart stem-cell trial misses primary endpoint, prompting cost cuts https://pharmadog.xyz/news/414063 pharmadog en 2026-09-17T00:39:34.000Z Researchers sue NIH over grant screening that they say violates First Amendment rights https://pharmadog.xyz/news/418204 pharmadog en 2026-09-17T00:00:00.000Z MHRA AI Commission Issues 44 Recommendations for Future UK Regulatory Framework https://pharmadog.xyz/news/418201 pharmadog en 2026-09-17T00:00:00.000Z FDA officials stress administration priorities in draft PDUFA VIII commitment letter https://pharmadog.xyz/news/418202 pharmadog en 2026-09-17T00:00:00.000Z EU officials outline major pharmaceutical legislative reforms at RAPS Convergence 2026 https://pharmadog.xyz/news/418203 pharmadog en 2026-09-17T00:00:00.000Z Former FDA chief Califf calls for regulatory overhaul and predicts AI assistants in future oversight https://pharmadog.xyz/news/418205 pharmadog en 2026-09-17T00:00:00.000Z Senate schedules hearing for FDA nominee as Novo teams with Anthropic on AI drug development https://pharmadog.xyz/news/416227 pharmadog en 2026-09-16T21:40:00.000Z 'Still a bull': Novo's CEO on honoring heritage and planning for the future amid corporate rebrand https://pharmadog.xyz/news/413235 pharmadog en 2026-09-16T20:20:15.000Z GOP Bill Seeks to Tilt Medicare Advantage Study Toward Insurers https://pharmadog.xyz/news/413087 pharmadog en 2026-09-16T19:17:40.000Z Senators probe nominee Chris Klomp’s influence on HHS health-policy and drug pricing https://pharmadog.xyz/news/412807 pharmadog en 2026-09-16T18:30:48.000Z Five major drugmakers cooperate with House investigation of Chinese military hospital trials https://pharmadog.xyz/news/412639 pharmadog en 2026-09-16T17:19:15.000Z Yale and Harvard faculty question benefits of FDA's 'America First' user fee provisions https://pharmadog.xyz/news/412575 pharmadog en 2026-09-16T16:29:10.000Z WHO sees declining Ebola transmission in DRC but warns months of work remain